Ragazzi et al used antimitochondrion antibody (AMA) immunostaining to distinguish between invasive breast carcinomas based on mitochondrial content.
Oncocytic cells have abundant, granular eosinophilic cytoplasm due to a high number of mitochondria.
Percent of Tumor Cells Staining with AMA
Designation
>= 70% as 3+ (strong)
oncocytic
>= 50% as 2+ (moderate) or 3+ strong, not oncocytic
mitochondrion-rich
where:
• Staining is strong when it is the same as oncocytic cells in a Warthin tumor.
• Staining is moderate when it is the same as cells of striated ducts that are rich in mitochondria.
An invasive carcinoma that did not meet either of these designations was termed not mitochondrion-rich.
Most oncoyctic and mitochondrion-rich carcinomas are high grade (Grade III) and overexpress HER2 (human epidermal growth factor receptor 2).
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology, Surgery, general, Obstetrics & Gynecology
ICD-10: ,